XBI Biotech sector
Company Analysis
Latest News
Biotech Sector Declines Amid Broad Market Sell-Off
The biotechnology sector, as measured by the XBI ETF, experienced a significant downturn of -4.24% during the regular trading session. This decline coincided...
🔴 XBI is trading 3.07% down today amid concern over a hawkish interest-rate stance
XBI is trading 3.07% down now at $163.06 as investors sell biotech and other high-risk growth assets amid concern that Federal Reserve Chair Kevin Warsh’s...
🟢 XBI is trading 3% up today as biotech shares extend recent momentum
XBI is trading 3.02% up now at $169.13 as biotech shares extend recent momentum amid positive sector sentiment. - The broader market is also modestly higher...
Biotech Sector Gains Amid Broad Market Rally and Positive Sentiment
The biotech sector, represented by the XBI ETF, is trading higher today, influenced by a general market upswing ahead of key inflation data and major tech...
Biotech Sector Continues Upward Trend on Strong Momentum
The biotechnology sector, as measured by the XBI ETF, is extending its recent gains, building on strong positive momentum from earlier in the week. This rally...
🔴 XBI is trading 3.4% down today after investors took profits following Moderna’s surge
XBI is trading 3.4% down at $163.72 as investors appear to take profits following Moderna’s dramatic cancer-vaccine-driven surge. - Edesa Biotech’s $25...
Biotech Sector Cools Off After Moderna-Sparked Rally
The biotech sector is experiencing a pullback after a significant surge the previous day, which was ignited by positive cancer vaccine trial results from...
🟢 XBI is trading 4% up today after positive Moderna-Merck melanoma-vaccine results
XBI is trading 3.99% up now at $167.26 after positive Phase 3 melanoma-vaccine results from Moderna and Merck. - Personalized mRNA treatment met its primary...
Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
The biotech sector, proxied by the XBI ETF, is trading significantly higher today following a major positive catalyst from industry leader Moderna. The company...
Biotech Sector Surges on Landmark Cancer Therapy Trial Success from Merck and Moderna
The biotechnology sector, as measured by the XBI ETF, is trading sharply higher in the pre-market session, driven by positive, high-profile clinical trial...
Biotech Sector Rallies on Argenx-Forte M&A Deal
The biotech sector is trading higher, with the XBI ETF up over 2%, driven by news of a significant acquisition. Argenx announced a tender offer to purchase...
🟢 XBI is trading 3.1% up today on biotech earnings strength and broader risk-on rally
XBI is trading 3.1% up today at $151.83, benefiting from a strong biotech sector rally and broader risk-on sentiment across U.S. equities. • Biotech names are...
Biotech Sector Rallies on Strong Earnings and Positive Market Sentiment
The biotechnology sector, as measured by the XBI ETF, is trading higher today, influenced by a combination of positive company-specific news and a broader...
🔴 XBI is trading 3.5% down today amid a sector-wide risk-off shift
XBI is trading 3.5% down at $146.14 amid a sharp biotech pullback and a sector-wide risk-off shift. • The biotechnology group is down over 3% without a single...
Biotech Sector Declines Without A Clear Catalyst
The biotechnology sector, as measured by the XBI ETF, is down over 3% in the current trading session without a clear, identifiable catalyst. While there was...
Biotech Sector Surges on Strong Earnings and Major M&A Deal
The biotechnology sector, as measured by the XBI ETF, rallied over 2% due to a combination of strong corporate earnings and significant merger and acquisition...
Biotech Stocks Decline on Broad Market Weakness
The biotechnology sector, as measured by the XBI ETF, traded lower on Tuesday, moving in sympathy with a broader risk-off sentiment in the market. There is no...
Biotech Sector Rallies on Blockbuster M&A Deal and Positive Trial Data
The biotechnology sector is experiencing a significant upward trend, with the XBI ETF climbing over 2%. Today's rally is largely fueled by the announcement...
Biotech Sector Rallies on Strong Novartis Earnings and Continued M&A Optimism
The biotech sector, represented by the XBI ETF, is trading higher today, driven by better-than-expected second-quarter earnings from industry giant Novartis....
Biotech Sector Declines Amid Broader Market Weakness and Company-Specific News
The biotechnology sector, as measured by the XBI ETF, experienced a downturn of -2.04% in the current session. This move appears to be driven by a combination...